Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age24-99
SponsorXavier University of Louisiana.

About this trial

Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP prescribing criteria. This study aims to explore1) Louisiana pharmacist and pharmacy capacity to provide PrEP under a state-based collaborative practice agreement, 2) a validated pharmacist education system addressing health disparities in PrEP prescribing and 3) the impact of state pharmacy based policies on equitable PrEP prescribing. Our central hypothesis is pharmacist trained in PrEP prescribing focusing on health disparities and implicit bias education and working with mentors in an implementation framework will have an increase in equitable PrEP prescribing

Eligibility criteria

Qualifiers

Community pharmacists in Louisiana providing PrEP prescriptions.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Education and Mentoring for Prescribing Pharmacists

Treatment groups

75 Participants
are divided into 1 treatment group

Sponsors and collaborators

Xavier University of Louisiana.

Lead sponsor

Louisiana Public Health Institute

Collaborator